Lente insulin
Lente Insulin
Lente insulin is a type of intermediate-acting insulin used in the management of diabetes mellitus. It is designed to mimic the body's natural pattern of insulin release and is typically administered to help control blood glucose levels throughout the day.
History
Lente insulin was developed as part of efforts to create insulin formulations with varying durations of action. It was introduced in the mid-20th century and became a popular choice for patients requiring insulin therapy due to its intermediate duration of action.
Composition
Lente insulin is a suspension of insulin zinc crystals in an acetate buffer. The formulation contains both amorphous and crystalline insulin, which contributes to its intermediate duration of action. The presence of zinc helps stabilize the insulin molecules, allowing for a slower release into the bloodstream.
Mechanism of Action
Lente insulin works by facilitating the uptake of glucose into cells, particularly in the liver, muscle, and adipose tissue. This action helps lower blood glucose levels and is essential for the management of diabetes. The intermediate action of Lente insulin is due to the gradual dissolution of the insulin zinc crystals, providing a steady release of insulin over time.
Administration
Lente insulin is typically administered via subcutaneous injection. The timing and dosage depend on the individual's needs, blood glucose monitoring, and the advice of a healthcare provider. It is often used in combination with other types of insulin to achieve optimal blood glucose control.
Advantages and Disadvantages
Advantages
- Provides a more stable and prolonged insulin action compared to short-acting insulins.
- Can be used in combination with other insulin types for tailored diabetes management.
Disadvantages
- May not provide adequate control of postprandial blood glucose spikes.
- Requires careful monitoring and adjustment to avoid hypoglycemia.
Related Pages
| Diabetes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD